108  Total SME IPOs listed in 2025

4,805.05 Crs.  Total funds raised in 2025

74  SME IPOs listed with Gain in 2025

34  SME IPOs listed with loss in 2025

108  Total SME IPOs listed in 2025

4,805.05 Crs.  Total funds raised in 2025

74  SME IPOs listed with Gain in 2025

34  SME IPOs listed with loss in 2025

108  Total SME IPOs listed in 2025

4,805.05 Crs.  Total funds raised in 2025

74  SME IPOs listed with Gain in 2025

34  SME IPOs listed with loss in 2025

108  Total SME IPOs listed in 2025

4805.05 Crs.  Total funds raised in 2,025.00

74  SME IPOs listed with Gain in 2025

34  SME IPOs listed with loss in 2025

Anthem Biosciences IPO (Anthem Biosciences Limited IPO) Detail

Anthem Biosciences IPO is a Book Building IPO listing on BSE,NSE exchange, with an ipo size of ₹ 3395.00 Cr. The company is based in Bangalore and caters to Pharmaceutical sector. Citigroup Global Markets India , J.P. Morgan India , Jm Financial , Nomura Financial Advisory And Securities (India) are the merchant bankers of Anthem Biosciences IPO. It is a MainBoard Upcoming IPO which filed its Draft Red Herring Prospectus (DRHP) on 31st December 2024.

Anthem Biosciences IPO open date is 14th July 2025 and close date is 16th July 2025. IPO Allotment Date is 17th July 2025 and Listing date is 21st July 2025.

IPO Category : MainBoard Upcoming
Exchange : BSE,NSE
Issue Type : Book Building

IPO Key Highlights

Anthem Biosciences IPO Date

Date of DRHP:
31st December 2024
IPO Open Date:
14th July 2025
IPO Close Date:
16th July 2025
IPO Allotment Date:
17th July 2025
Initiation of Refund:
18th July 2025
IPO Listing Date:
21st July 2025

Anthem Biosciences IPO Info, Size, Subscription

Anthem Biosciences IPO size is ₹ 3395.00 Cr. with IPO price of ₹ 570.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.

IPO Size :
₹ 3,395.00 Cr.

Issue Price:
₹ 570.00

Market Capitalisation :
₹ 31,867.39 Cr.

PE multiple :
70.62

Subscription :
[●]

Pre Issue Promoter Holding :
71.11 %

Post Issue Promoter Holding :
[●]

Anthem Biosciences IPO Information

Sub Sector : an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization
Anthem Bioscience Limited, an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. They are one of the few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilities across drug discovery, development, and commercial manufacturing, according to the F&S Report. As a one-stop service provider, they serve a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally. They are one of the youngest Indian CRDMO companies and the fastest Indian CRDMO to achieve a milestone of ₹10,000 million of revenue within 14 years of operations, reaching this milestone in Fiscal 2021, according to the F&S Report. They also recorded the highest revenue growth in
Show More

Object of Issue (Anthem Biosciences IPO Objectives)

  • Achieve the benefits of listing
  • Offer for Sale

Citigroup Global Markets India Private Limited is the book-running lead manager of the Anthem Biosciences IPO. Kfin Technologies Limited is the Registrar for Anthem Biosciences IPO.

Anthem Biosciences IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.

What is Anthem Biosciences IPO?

Anthem Biosciences IPO, based in Bangalore, operates in the   Pharmaceutical sector with a focus on an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization. The company is launching its MainBoard Upcoming IPO on the BSE,NSE exchange, using the Book Building Issue method. Anthem Biosciences IPO size is ₹ 3395.00 Cr. with fresh issue size of ₹ [●] and Offer for sale being ₹ 3395.00 Cr.

When is Anthem Biosciences IPO allotment?

The IPO allotment date for Anthem Biosciences IPO is expected to be 17th July 2025, after the finalization of basis of allotment. Investors can check Anthem Biosciences IPO allotment status on the registrars website, Kfin Technologies Limited . Anthem Biosciences IPO refund dates are 18th July 2025.

When is Anthem Biosciences IPO listing date?

Anthem Biosciences IPO is expected to be listed on 21st July 2025.

What is the price band for Anthem Biosciences IPO?

The upper price band for the Anthem Biosciences IPO is set at ₹ 570.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.

What is Anthem Biosciences IPO Review?

For IPO analysis on Anthem Biosciences IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.

How to Apply for Anthem Biosciences IPO?

To apply for the Anthem Biosciences IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 16th July 2025. After submission, funds are blocked until the basis of allotment of Anthem Biosciences IPO is finalised.

Who is the merchant banker of Anthem Biosciences IPO?

The merchant banker for Anthem Biosciences IPO is Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited . Citigroup Global Markets India Private Limited , J.P. Morgan India Private Limited , Jm Financial Limited , Nomura Financial Advisory And Securities (India) Private Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Anthem Biosciences IPO RHP for further details.

Who is the Registrar of Anthem Biosciences IPO?

The registrar for Anthem Biosciences IPO is Kfin Technologies Limited . Investors can go to Kfin Technologies Limited registrar website for IPO allotment status, refund processing, and other queries related to Anthem Biosciences IPO through their official website or helpline.

What is the Anthem Biosciences IPO subscription?

Anthem Biosciences IPO was subscribed [●] times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.

IPO Key Highlights

Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

Upcoming IPO List

Smartworks Coworking Spaces Limited

  Corporate Solutions

  New Delhi


Boat - Imagine Marketing Limited

  Electric Equipments

  Mumbai


Bajaj Energy Limited

  Power and Energy

  Mumbai


NSDL National Securities Depository Limited

  Banking and Finance

  Mumbai


Fabindia Limited

  Retail

  New Delhi


Thinking of
Listing Your Business through
SME IPO?
We can Help!
Contact Us Today

Upcoming IPO List

Smartworks Coworking Spaces Limited

  Corporate Solutions

  New Delhi


Boat - Imagine Marketing Limited

  Electric Equipments

  Mumbai


Bajaj Energy Limited

  Power and Energy

  Mumbai


NSDL National Securities Depository Limited

  Banking and Finance

  Mumbai


Fabindia Limited

  Retail

  New Delhi


Read more details of this IPO

Peer Companies Of This Sector

FAQs

Anthem Biosciences IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Anthem Biosciences Financial Review Page

Anthem Biosciences IPO subscription was X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.

Anthem Biosciences IPO listed at a listing price of against the offer price of 570.00.

The current market price of Anthem Biosciences is .

Services

IPO Advisory
IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
IPO Readiness
IPO Readiness
IPO Roadmap by improving Business Efficiencies, Financial Parameters and Corporate Structure to become IPO ready.
Fund Raising
Fund Raising
Fuelling a company's growth through Pre IPO Fund Raise, Private Equity, and Angel Investing.
SME : Business Scaling
SME Business Upscaling
Provide support to build a scalable SME business by unleashing the SME potential.
Post IPO Montoring
Post IPO Mentoring
Assisting with post IPO regulatory requirements and Performance Monitoring to achieve the milestone of Mainboard migration.

Thinking of
Listing Your Business through SME IPO?

We can help! Contact Us

Why Us?

  • Leading portal for IPOs
  • End to End Solutions
  • Known for Transparency